Click to view the conference video livestream
Click to view conference details

Conference Agenda

Friday, September 22, 2017

WHAT EVERY BREAST CANCER PATIENT NEEDS TO KNOW ABOUT INTEGRATIVE ONCOLOGY:
Supportive and Protective Practices

12:00 Noon

REGISTRATION

Introduction to Integrative Oncology

1:00 PM

What is Integrative Oncology and How Can it Help?

  • Inflammation: The Precursor to Disease and Disease Progression
  • Nutritional Healing: Food as Medicine

Laura James, ND, FABNO, Red Cedar Wellness Center

1:45 PM

Overview of the Society for Integrative Oncology Guidelines for Patients

Heather Greenlee, ND, PhD, MPH,  FHCRC/SCCA

2:15 PM

Q&A

Moderator: Lynda Weatherby, Patient Advocate

2:30 PM

BREAK

Understanding Additional Integrative Therapies

2:45 PM

A Deeper Dive into Integrative Oncology for Breast Cancer

  • Mindfulness and Meditation
  • Supplements for Breast Cancer

Astrid Pujari, MD, The Pujari Center for Integrative Medicine

3:30 PM

Other Healing Practices

  • Acupuncture
  • Massage Therapy
  • Reiki and Energy Healing
  • Chinese Herbalist/Oriental Medicine
  • Medical Marijuana

Gregory Rudolf, MD, Swedish Medical Group

Samantha Desmond, ND, MACP, BHC, LMP, Monroe Therapeutic Massage

Gayle Johnson, EVOLVE

Elisha Bokman, ND, LAc EAMP NaturoMedica

Joseph Rosales, MD, Virginia Mason Medical Center

4:30 PM

Q&A

Moderators: Rebecca Seago-Coyle and Andrea Hutton, Patient Advocates

Vendors and Sponsor Resources

5:00 PM

Learning and Accessing Resources from Our Partners Teri Pollastro, Patient Advocate

5:30 PM

RECEPTION

Sponsored in part by NanoString Technologies

Saturday, September 23, 2017

7:30 AM REGISTRATION AND CONTINENTAL BREAKFAST
8:30 AM Welcome and Introductions Beth Caldwell, JD, METUP Founder and Conference Co-Chair
Lynda Weatherby, MHA, Conference Co-Chair
8:40 AM Keynote – “Addressing Disparities in MBC Outcomes and Research” Bridgette Hempstead, Cierra Sisters
Shawn Johnson, MD, Harvard Medical School, The Broad Institute

HOT TOPICS in MBC

New Treatments & Clinical Trials
9:10 AM Introduction Session Moderator: Julie Gralow, MD, UW/SCCA/FHCRC

9:15 AM

Genomics

  • Research Applications
  • Clinical Applications
Panel:
Eric Konnick, MD, UW, MS UWMC
Kevin Cheung, MD, FHCRC/SCCA
VK Gadi, MD, PhD, UW/FHCRC/SCCA
9:35 AM Q&A Moderator: Teri Pollastro, Patient Advocate

9:45 AM

Immunotherapies

  • Vaccine Therapies
  • Immunotherapy
  • Clinical Applications
Panel:
Sasha Stanton, MD, PhD, UW/SCCA/FHCRC
Jennifer Specht, MD, UW/SCCA/FHCRC
10:05 AM Q&A Moderator: Teri Pollastro, Patient Advocate

10:15 AM

Clinical Trials Opportunities

  • Basic Research
  • Translational Research
  • Patient Advocacy
Panel:
Kevin Cheung, MD, FHCRC/SCCA
VK Gadi, MD, PhD, UW/FHCRC/SCCA
10:45 AM Q&A Moderator: Teri Pollastro, Patient Advocate
11:00 AM BREAK  

BREAKOUT SESSIONS: Latest Treatment Options
by Subtype and Location of Metastases

Metastatic Breast Cancer by Overview Subtypes
11:15 AM Triple Negative Breast Cancers Kristine Rinn, MD, Swedish Cancer Institute
Moderator: Rebecca Seago-Coyle, Patient Advocate
HER2 Breast Cancers Erin Ellis, MD, Swedish Cancer Institute
Moderator: Andrea Hutton, Patient Advocate
Estrogen Positive Breast Cancers Nanette Robinson, MD, Virginia Mason Medical Center
Moderator: Lynda Weatherby, MHA,  Patient Advocate
Lobular Breast Cancer 101:  Fundamentals Steffi Oesterreich, PhD, University of Pittsburgh Cancer Institute
Hannah Linden, MD, UW/FHCRC/SCCA
Moderator: Joyce Bittinger, Patient Advocate
12:15 PM LUNCH  
Treatment Options by Location of Metastasis
1:00 PM Bone Metastases Julie Gralow, MD, UW/SCCA/FHCRC
Janice Kim, MD, UW/SCCA
Moderator: Lynda Weatherby, MHA,  Patient Advocate
Brain Metastases Alison Conlin, MD, Providence Cancer Center, Portland, Oregon
Chris Loiselle, MD, Swedish Cancer Institute
Eddie Marzbani, MD, SCCA/Northwest Hospital & Medical Center
Moderator: Beth Caldwell, Patient Advocate
Liver and Lung Metastasis Shilpen Patel, MD, UWMC
Raymond Yeung, MD, UWMC
Moderator: Teri Pollastro, Patient Advocate
Lobular Breast Cancer 102:  Metastasis and Clinical Steffi Oesterreich, PhD, University of Pittsburgh Cancer Institute
Hannah Linden, MD, UW/FHCRC/SCCA
Moderator: Joyce Bittinger, Patient Advocate
1:55 PM Transition back to general session

NATIONAL ISSUES in MBC

The Changing Landscape of MBC: Why Our Data and Voices MATTER
2:00 PM

Data, Research & MBC – Why it Matters

  • Understanding the Data We Have
  • Collecting the Right Data in the Future
  • Using Evidence for Action
Moderators:
Corrie Painter, PhD, MBC Project
Lynda Weatherby, MHA, Patient AdvocatePanel:
Ruth Etzioni, PhD, FHCRC
Hank Kaplan, MD, Swedish Cancer Institute
Marc Hurlbert, PhD, MBC Alliance
Shirley Mertz, JD, MBC Network
Matt Wood, PhD Amazon Web Services
 3:15 PM BREAK  
Advocacy and Activism: How to Get Involved and Be the Change That’s Needed
3:30 PM The Evolution of the Metastatic Breast Cancer Agenda Shirley Mertz, JD, MBC Network
Beth Fairchild, METAvivor
Beth Caldwell, JD, METUP
3:45 PM Your Role as an MBC Advocate Moderator:
Shawn Johnson, MD, Harvard Medical School, The Broad Institute
Panel:
Catherine Omerod, LBBC
Bridgette Hempstead, Cierra Sisters
Andrea Hutton, Author and Patient Advocate
4:10 PM Q&A Moderator: Andrea Hutton, Patient Advocate

4:20 PM

Making a Commitment to the Cause

  • What Are Our Top Priorities?
  • Increasing Investment in Metastatic Research
  • Improving Clinical Trial Access
  • Improving Treatment for Cancers with Poorer Outcomes
  • Accessing Financial and Support Benefits
  • How Can We Move Forward Together?

Moderator:
Shirley Mertz, JD, MBC Network and Co-Chair, MBC Alliance Research Taskforce

Panel:
Beth Caldwell, JD, METUP
Beth Fairchild, METAvivor
Shawn Johnson, MD, Harvard Medical School, The Broad Institute
Marc Hurlbert, PhD, MBCA, BCRF
Catherine Omerod, LBBC
Victoria Wolodzko, Susan G. Komen Headquarters

 

4:50 PM Q&A Moderator: Beth Caldwell, Patient Advocate
5:00 PM Closing Remarks Beth Caldwell, JD, METUP Founder and Conference Co-Chair
5:15 PM RECEPTION  

The Northwest Metastatic Breast Cancer Conference is supported by Susan G. Komen Puget Sound in partnership with Amazon Web Services, Swedish Cancer Institute, Eisai, Pfizer Oncology, Cascadian Therapeutics, Novartis Oncology, Odonate Therapeutics, Seattle Cancer Care Alliance, Fred Hutch and Seattle Genetics.